Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Label Study to Explore Tissue Histopathology Following Reduction in Skin Surface Using the Ellacor® Micro-Coring™ Procedure in an Abdominoplasty Model.

NCT06421207 is registered in ClinicalTrials.gov with Cytrellis Biosystems, Inc. as lead sponsor.

NCT NCT06421207
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06421207 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Label Study to Explore Tissue Histopathology Following Reduction in Skin Surface Using the Ellacor® Micro-Coring™ Procedure in an Abdominoplasty Model.
Lead sponsor
Cytrellis Biosystems, Inc.
Phase
Not applicable
Overall status
Completed
Start date
February 22, 2023
Completion date
October 4, 2023
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

histopathology, rhytides, wrinkle